Total Payments
$1.7M
2024 Payments
$217,699
Companies
32
Transactions
1,964
Medicare Patients
867
Medicare Billing
$167,289
Payment Breakdown by Category
Other$1.1M (67.2%)
Consulting$306,819 (18.1%)
Travel$195,338 (11.5%)
Food & Beverage$50,215 (3.0%)
Research$2,008 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.1M | 369 | 64.2% |
| Consulting Fee | $306,819 | 129 | 18.1% |
| Travel and Lodging | $195,338 | 651 | 11.5% |
| Honoraria | $51,451 | 7 | 3.0% |
| Food and Beverage | $50,215 | 806 | 3.0% |
| Unspecified | $2,008 | 2 | 0.1% |
Payments by Type
General
$1.7M
1,962 transactions
Research
$2,008
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $280,664 | 352 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $269,834 | 497 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $225,804 | 238 | $0 (2024) |
| ABBVIE INC. | $214,958 | 230 | $0 (2024) |
| BeiGene USA, Inc. | $169,652 | 133 | $0 (2024) |
| Genentech USA, Inc. | $169,310 | 181 | $0 (2024) |
| Secura Bio, Inc. | $151,555 | 77 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $49,792 | 35 | $0 (2024) |
| Adaptive Biotechnologies Corporation | $24,953 | 28 | $0 (2024) |
| ADC Therapeutics America, Inc. | $21,585 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $217,699 | 179 | BeiGene USA, Inc. ($57,794) |
| 2023 | $198,421 | 216 | BeiGene USA, Inc. ($69,669) |
| 2022 | $232,028 | 215 | SECURA BIO, INC. ($50,651) |
| 2021 | $184,316 | 194 | Pharmacyclics LLC, An AbbVie Company ($44,231) |
| 2020 | $153,589 | 180 | AstraZeneca Pharmaceuticals LP ($54,910) |
| 2019 | $340,499 | 470 | AbbVie, Inc. ($80,211) |
| 2018 | $251,776 | 349 | AbbVie, Inc. ($63,558) |
| 2017 | $113,278 | 161 | Genentech USA, Inc. ($48,715) |
All Payment Transactions
1,964 individual payment records from CMS Open Payments — Page 1 of 79
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | F. Hoffmann-La Roche AG | Venclexta (Biological) | — | In-kind items and services | $1,535.45 | Research |
| Study: Best Practices to Overcoming Challenges in Initiating Venetoclax for Patients with Chronic Lymphocytic Leukemia: Results from a United States Community-Based Healthcare Practitioner Survey • Category: BioOncology | ||||||
| 12/31/2024 | F. Hoffmann-La Roche AG | Venclexta (Biological) | — | In-kind items and services | $472.73 | Research |
| Study: Best Practices to Overcoming Challenges in Initiating Venetoclax for Patients with Chronic Lymphocytic Leukemia: Results from a United States Community-Based Healthcare Practitioner Survey • Category: BioOncology | ||||||
| 12/12/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Oncology | ||||||
| 12/10/2024 | ADC Therapeutics America, Inc. | — | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| 12/04/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 11/22/2024 | Genentech USA, Inc. | Polivy (Biological) | Food and Beverage | In-kind items and services | $53.10 | General |
| Category: BioOncology | ||||||
| 11/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $102.67 | General |
| 11/13/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $34.84 | General |
| 11/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $8.52 | General |
| 11/06/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Secura Bio, Inc. | COPIKTRA (Drug) | Honoraria | Cash or cash equivalent | $8,627.18 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 10/30/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $312.50 | General |
| 10/29/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 10/29/2024 | Secura Bio, Inc. | COPIKTRA (Drug) | Food and Beverage | In-kind items and services | $213.34 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 10/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Travel and Lodging | In-kind items and services | $308.95 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Travel and Lodging | In-kind items and services | $270.00 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Travel and Lodging | In-kind items and services | $119.00 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Travel and Lodging | In-kind items and services | $58.75 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $103.23 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Travel and Lodging | In-kind items and services | $81.27 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Best Practices to Overcoming Challenges in Initiating Venetoclax for Patients with Chronic Lymphocytic Leukemia: Results from a United States Community-Based Healthcare Practitioner Survey | F. Hoffmann-La Roche AG | $2,008 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 198 | 480 | $67,054 | $44,181 |
| 2022 | 3 | 194 | 398 | $78,264 | $37,073 |
| 2021 | 4 | 213 | 505 | $77,942 | $45,487 |
| 2020 | 5 | 262 | 547 | $87,014 | $40,548 |
Total Patients
867
Total Services
1,930
Medicare Billing
$167,289
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 84 | 323 | $49,403 | $33,513 | 67.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 101 | 144 | $15,012 | $9,248 | 61.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $2,639 | $1,420 | 53.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 78 | 223 | $36,918 | $24,073 | 65.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 105 | 149 | $16,464 | $9,358 | 56.8% |
| M0220 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise | Facility | 2022 | 11 | 26 | $24,882 | $3,642 | 14.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 82 | 304 | $51,320 | $31,664 | 61.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 87 | 127 | $13,716 | $8,921 | 65.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 36 | $8,460 | $2,998 | 35.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 28 | 38 | $4,446 | $1,903 | 42.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 95 | 299 | $45,044 | $24,650 | 54.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 81 | 107 | $11,047 | $5,121 | 46.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 55 | 76 | $16,501 | $4,706 | 28.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 48 | $11,040 | $3,968 | 35.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 17 | 17 | $3,382 | $2,103 | 62.2% |
About Dr. Ryan Jacobs, MD
Dr. Ryan Jacobs, MD is a Internal Medicine healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1114160082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Jacobs, MD has received a total of $1.7M in payments from pharmaceutical and medical device companies, with $217,699 received in 2024. These payments were reported across 1,964 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.1M).
As a Medicare-enrolled provider, Jacobs has provided services to 867 Medicare beneficiaries, totaling 1,930 services with total Medicare billing of $167,289. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology, Hematology
- Location Charlotte, NC
- Active Since 04/08/2009
- Last Updated 07/15/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1114160082
Products in Payments
- IMBRUVICA (Drug) $409,293
- CALQUENCE (Drug) $219,525
- Imbruvica (Drug) $193,850
- BRUKINSA (Drug) $171,210
- Venclexta (Drug) $143,769
- COPIKTRA (Drug) $117,522
- VENCLEXTA (Biological) $96,200
- Rituxan (Biological) $43,851
- VENCLEXTA (Drug) $35,933
- FARYDAK (Drug) $33,937
- clonoSEQ (Device) $24,761
- GAZYVA (Biological) $23,736
- ELITEK (Drug) $18,896
- Copiktra (Drug) $18,600
- Epkinly (Drug) $12,094
- EPKINLY (Drug) $11,188
- UKONIQ (Drug) $8,953
- Venclexta (Biological) $7,370
- Yescarta (Drug) $6,269
- MONJUVI (Drug) $5,855
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charlotte
Saad Usmani, Md, MD
Internal Medicine — Payments: $747,509
Internal Medicine $747,509
Michael Rinaldi, Md, MD
Internal Medicine — Payments: $646,787
Internal Medicine $646,787
Dr. Richard Browne, M.d, M.D
Internal Medicine — Payments: $638,169
Internal Medicine $638,169
Sanjeev Gulati, Md, MD
Internal Medicine — Payments: $598,822
Internal Medicine $598,822
Dr. Raymond Thertulien, M.d, M.D
Internal Medicine — Payments: $584,601
Internal Medicine $584,601
Mohamed Salem, Md, MD
Internal Medicine — Payments: $487,246
Internal Medicine $487,246